Pharmaceutical

top of page

WSE_logo_artwork-rgb_outline_dark green.png

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

Ultragenyx’s $203 Million Voucher Deal Offers a Funding Boost

6 days ago1 min read

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Liquidia Pays $380.7 Million to Clear YUTREPIA’s Legal Path

Oct 151 min read

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavor: NervGen Begins Pivotal Spinal Cord Injury Trial

Worthy Endeavors

Oct 131 min read

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

UnitedHealth’s Earnings Beat Strengthens Its Turnaround

Oct 131 min read

Syndax Trial Failure Narrows Its Growth Outlook

Syndax Trial Failure Narrows Its Growth Outlook

Syndax Trial Failure Narrows Its Growth Outlook

Oct 131 min read

Merck’s Keytruda Expansion Hits a European Roadblock

Merck’s Keytruda Expansion Hits a European Roadblock

Merck’s Keytruda Expansion Hits a European Roadblock

Oct 131 min read

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Genmab Rises as AbbVie Cancer Trial Opens Growth Opportunity

Oct 71 min read

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Shionogi Bets $2 Billion on a US Rare-Disease Drugmaker

Pharma Investments

Oct 61 min read

Eli Lilly’s Next Obesity Drug Raises the Bar Again

Eli Lilly’s Next Obesity Drug Raises the Bar Again

Eli Lilly’s Next Obesity Drug Raises the Bar Again

Oct 11 min read

AstraZeneca Seeks US Approval for Lung Cancer Drug Combination

AstraZeneca Seeks US Approval for Lung Cancer Drug Combination

AstraZeneca Seeks US Approval for Lung Cancer Drug Combination

Oct 11 min read

Roche Wins New US Approval for Gazyva

Roche Wins New US Approval for Gazyva

Roche Wins New US Approval for Gazyva

Oct 11 min read

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

ADARx Raises $446 Million as Biotech IPOs Regain Momentum

Sep 281 min read

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Genentech Makes a $1.5 Billion Bet on AI-Designed Cancer Drugs

Sep 281 min read

Viking’s Weight-Loss Drug Has a New Selling Point: Fewer Injections

Viking’s Weight-Loss Drug Has a New Selling Point: Fewer Injections

Viking’s Weight-Loss Drug Has a New Selling Point: Fewer Injections

Sep 242 min read

Grail’s Cancer Test Faces Its Most Important Question Yet

Grail’s Cancer Test Faces Its Most Important Question Yet

Grail’s Cancer Test Faces Its Most Important Question Yet

Sep 241 min read

2

bottom of page